Mostrar el registro sencillo del ítem
Synthesis, 5-hydroxytryptamine1A receptor affinity and docking studies of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives
dc.contributor.author | Pessoa-Mahana H. | |
dc.contributor.author | Núñez C.U. | |
dc.contributor.author | Araya-Maturana R. | |
dc.contributor.author | Barría C.S. | |
dc.contributor.author | Zapata-Torres G. | |
dc.contributor.author | Pessoa-Mahana C.D. | |
dc.contributor.author | Iturriaga-Vasquez P. | |
dc.contributor.author | Mella-Raipán J. | |
dc.contributor.author | Reyes-Parada M. | |
dc.contributor.author | Celis-Barros C. | |
dc.date.accessioned | 2020-09-02T22:25:48Z | |
dc.date.available | 2020-09-02T22:25:48Z | |
dc.date.issued | 2012 | |
dc.identifier | 10.1248/cpb.60.632 | |
dc.identifier.citation | 60, 5, 632-638 | |
dc.identifier.issn | 00092363 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5787 | |
dc.description | A series of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives (12a-h) was synthesized and evaluated for binding affinity at the human 5-hydroxytryptamine1A receptor (5-HT1AR) compounds (12b) and (12h) showed the highest 5-HT1A receptor affinity (IC 50-=15 nM). Molecular docking studies with all the compounds in a homology model of 5-HT1A showed that the main interaction anchoring the ligand in the receptor was a charge-reinforced bond between the protonated nitrogen atom (N-4) of the piperazine ring and Aspartate3.32. © 2012 The Pharmaceutical Society of Japan. | |
dc.language.iso | en | |
dc.publisher | Pharmaceutical Society of Japan | |
dc.subject | Binding | |
dc.subject | Docking | |
dc.subject | Indolylalkylarylpiperazine | |
dc.subject | Synthesis | |
dc.subject | 3 [3 (4 pyrimidin 2 yl 1 piperazinyl) propyl] 1h indol | |
dc.subject | 3 [3 [4 (2 methoxyphenyl) 1 piperazinyl] propyl] 1h indol | |
dc.subject | aspartic acid | |
dc.subject | indole derivative | |
dc.subject | ligand | |
dc.subject | piperazine | |
dc.subject | serotonin 1A receptor | |
dc.subject | unclassified drug | |
dc.subject | indole derivative | |
dc.subject | piperazine derivative | |
dc.subject | serotonin 1A receptor | |
dc.subject | article | |
dc.subject | binding affinity | |
dc.subject | controlled study | |
dc.subject | drug synthesis | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | molecular docking | |
dc.subject | receptor affinity | |
dc.subject | binding site | |
dc.subject | chemistry | |
dc.subject | computer simulation | |
dc.subject | metabolism | |
dc.subject | protein tertiary structure | |
dc.subject | structure activity relation | |
dc.subject | synthesis | |
dc.subject | Aspartic Acid | |
dc.subject | Binding Sites | |
dc.subject | Computer Simulation | |
dc.subject | Humans | |
dc.subject | Indoles | |
dc.subject | Piperazines | |
dc.subject | Protein Structure, Tertiary | |
dc.subject | Receptor, Serotonin, 5-HT1A | |
dc.subject | Structure-Activity Relationship | |
dc.title | Synthesis, 5-hydroxytryptamine1A receptor affinity and docking studies of 3-[3-(4-aryl-1-piperazinyl)-propyl]-1H-indole derivatives | |
dc.type | Article |